Quality Investor
About 

Chord Energy Corporation

Rank #240Decline

CHRD · Nasdaq · Energy

Chord Energy Corporation (CHRD) — Rank #240 by gross profitability (GP/assets 0.28) · ROE 0.5% · Piotroski F-Score 5 / 9.

As-of 2026-09-15 · CIK 0001486159 · all metrics point-in-time as of the filing date.

About

Chord Energy Corporation operates as an independent exploration and production company in the United States.

Show more

The company engages in the acquisition, exploration, development and production of crude oil, natural gas, and natural gas liquids in the Williston Basin. It sells its products to refiners, marketers, and other purchasers that have access to pipeline and rail facilities. The company was formerly known as Oasis Petroleum Inc. and changed its name to Chord Energy Corporation in July 2022.

Chord Energy Corporation was founded in 2007 and is headquartered in Houston, Texas.

Industry
Oil & Gas E&P
Sector
Energy
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
December 31

Price History

CHRD+162.8% · +21.3% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E, P/B, and dividend yield matter most — book value provides a floor.

Market Cap

$8.52B

P/E (annual)

210.4

P/S (annual)

1.7

P/B

1.0

P/OCF (annual)

4.2

Shareholder Yield

-5.9%

Employees

676

Industry

Oil & Gas E&P

Exchange

Nasdaq

Signal Flags

1 green2 yellow4 red
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak
Dilution above 2%Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation
Disclosure regressionA previously-disclosed line item is no longer reported — worth checking the filing for why
Revenue declining YoYRevenue contracted year over year
Operating margin decliningOperating margin lower than prior year
Balance sheet deterioratingNet cash collapsed with receivables or inventory outpacing revenue
Valuation convergenceEPS declining, shares diluting, and revenue growth decelerating simultaneously

Quality Profile

Profitability

1/1 pass
GP / assets
0.28
Return on equity
0.5%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.64
Current ratio
1.22×
Net cash
-$869.79M

Cash Flow

1/1 pass
Positive FCF
N/A
Cash-backed earnings
N/A
Accruals healthy
PASS
SBC / revenue
0.5%

Growth

0/2 pass
Revenue growth
-7.1%
Piotroski F-Score
5 / 9
Share dilution
9.7%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

2 of 5 thresholds not computable from filed data.

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

142.4xExpensive
2.3xmed 7.6x142.4x

P / S

Price / revenue per share

1.3xFair
0.2xmed 1.2x19.5x

P / B

Price / book value per share

0.8xFair
0.1xmed 0.7x19.5x

Asset value and restructuring potential (balance-sheet strength) are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.28

Primary signal (Novy-Marx).

3rd of 6 SIC 13 peers

Return on equity

0.5%

Gross margin

80.0%

3rd of 6 SIC 13 peers

Revenue growth (YoY)

-7.1%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

10.2%

Revenue CAGR (5Y)

42.0%

Earnings CAGR (3Y)

-71.2%

FCF CAGR (3Y)

—

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.64

4th of 6 SIC 13 peers (best = lowest)

Current ratio

1.22×

6th of 6 SIC 13 peers

Quick ratio

1.10×

Net cash

-$869.79M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

—

Operating cash flow minus capex.

Positive free cash flow

N/A

FCF / net income

—

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

N/A

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.5%

Stock-based comp intensity.

Dividend safety

Composite score

0.5 / 5

Weak
Payout ratio
714.7%0/5 Weak
FCF coverage
N/A0/5 Weak
Dividend growth streak
0 yr0/5 Weak
Balance-sheet health
D/E 0.64 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

5 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20202025
Decline
Hypergrowth
Capital Return
View full financial statements →